Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Molecular Therapy. Methods & Clinical Development|May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.Science Advances|February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberinPike-See Cheah, Shilpa Prabhakar, David Yellen, et al.Neuro-Oncology|July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningiomaSteven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.American Journal of Medical Genetics. Part A|April 25, 2017
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosisJaishri O Blakeley, Annette Bakker, Anne Barker, et al.American Journal of Human Genetics|March 16, 2007
Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levelsDavid Reich, Nick Patterson, Vijaya Ramesh, et al.Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.American Journal of Medical Genetics. Part A|January 29, 2011
Back to the future: proceedings from the 2010 NF ConferenceSusan M Huson, Maria T Acosta, Allan J Belzberg, et al.American Journal of Medical Genetics. Part A|March 26, 2019
First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeuticsKatherine A Rauen, Abeer Alsaegh, Shay Ben-Shachar, et al.Plos One|June 14, 2018
Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2, Robert Allaway, Steve P Angus, et al.American Journal of Medical Genetics. Part A|January 21, 2014
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapiesBrigitte C Widemann, Maria T Acosta, Sylvia Ammoun, et al.Pageof 7